The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schultes Birgit C since 2025.
This trader's CIK number is 2051419.
At the time of last reporting, Schultes Birgit C was the EVP, Chief Scientific Officer of Intellia Therapeutics, Inc.. (stock ticker symbol NTLA).
Also see all insider trading activities at Intellia Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NTLA | 0 | $0 | 31 | $538 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-10-01 | NTLA | Sale | 31 | 17.38 | 538 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schultes Birgit C (EVP, Chief Scientific Officer of Intellia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.